Divi's Laboratories Limited
Divi's Laboratories Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: DIVISLAB and BSE: 532488 (ISIN INE361B01024).
It has a market capitalisation of ₹2.41 lakh crore, a last close of ₹9,087 on 2026-10-19, a one-year return of 37.2%.
Valuation: a price-to-earnings ratio of 82.33x, a price-to-book ratio of 14.37x, a dividend yield of 0.3%.
Profitability: return on equity of 16.2%, return on capital employed of 20.4%, an operating margin of 35.3%.
Growth: sales growth of 10.8% a year over three years, net profit growth of 12.1% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.00x, promoter holding of 51.9%.
| Metric | Value |
|---|---|
| Market capitalisation | 2.41 L Cr |
| Last close | ₹9,087 |
| P/E (TTM) | 82.33x |
| P/B | 14.37x |
| Dividend yield | 0.3% |
| ROE (FY) | 16.2% |
| ROCE (FY) | 20.4% |
| Operating margin (TTM) | 35.3% |
| Sales growth, 3-year CAGR | 10.8% |
| Profit growth, 3-year CAGR | 12.1% |
| Debt / equity | 0.00x |
| Promoter holding | 51.9% |
| 1-year return | 37.2% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means